Business Wire (Wed, 20-Nov 8:30 AM ET)
Business Wire (Thu, 14-Nov 8:30 AM ET)
HCA Healthcare Named a Best Employer for Veterans by Military Times for Fifth Consecutive Year
Business Wire (Mon, 11-Nov 8:30 AM ET)
HCA Healthcare Reports Third Quarter 2024 Results
Business Wire (Fri, 25-Oct 7:30 AM ET)
Bullish On HCA? You Might Want To Consider This Credit Put Spread Expiring in 19 Days
Market Chameleon (Tue, 22-Oct 9:11 AM ET)
HCA Healthcare to Host Sixth Annual "Crush the Crisis" National Prescription Drug Take Back Day
Business Wire (Tue, 22-Oct 8:30 AM ET)
HCA Healthcare, Inc. to Present at November Healthcare Conferences
Business Wire (Thu, 17-Oct 5:00 PM ET)
Business Wire (Tue, 1-Oct 2:07 PM ET)
HCA Healthcare, Inc. 3rd Quarter 2024 Earnings Conference Call
Business Wire (Thu, 26-Sep 4:00 PM ET)
HCA Healthcare Presents 2024 Awards of Distinction
Business Wire (Tue, 24-Sep 4:30 PM ET)
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of June 2024, the firm owned and operated 188 hospitals, 123 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
Hca Healthcare trades on the NYSE stock market under the symbol HCA.
As of December 13, 2024, HCA stock price climbed to $313.93 with 1,256,216 million shares trading.
HCA has a beta of 0.64, meaning it tends to be less sensitive to market movements. HCA has a correlation of 0.08 to the broad based SPY ETF.
HCA has a market cap of $81.02 billion. This is considered a Large Cap stock.
Last quarter Hca Healthcare reported $17 billion in Revenue and $4.90 earnings per share. This fell short of revenue expectation by $-53 million and missed earnings estimates by -$.07.
In the last 3 years, HCA traded as high as $417.14 and as low as $164.47.
The top ETF exchange traded funds that HCA belongs to (by Net Assets): VTI, VOO, SPY, IVV, VTV.
HCA has underperformed the market in the last year with a price return of +20.6% while the SPY ETF gained +31.7%. HCA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -19.7% and -3.5%, respectively, while the SPY returned +8.4% and +0.9%, respectively.
HCA support price is $306.13 and resistance is $316.53 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HCA shares will trade within this expected range on the day.